Pappagallo, Marco
Inturrisi, Charles E.
Manfredi, Paolo L.
Funding for this research was provided by:
Relmada Therapeutics, Inc
Article History
Accepted: 17 December 2021
First Online: 11 January 2022
Declarations
:
: Marco Pappagallo, Charles Inturrisi and Paolo Manfredi are paid consultants for Relmada Therapeutics. Charles Inturrisi and Paolo Manfredi are inventors on patents and patent applications related to dextromethadone.
: This Letter is funded by Relmada Therapeutics.
: Marco Pappagallo, Charles Inturrisi and Paolo Manfredi prepared the Letter, approved the final version for publication and agree to be accountable for its contents.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.